TY - JOUR AU - Schaible, H. G. PY - 2014 DA - 2014// TI - Nociceptive neurons detect cytokines in arthritis JO - Arthritis Res Ther. VL - 16 UR - https://doi.org/10.1186/s13075-014-0470-8 DO - 10.1186/s13075-014-0470-8 ID - Schaible2014 ER - TY - JOUR AU - Steiner, G. AU - Tohidast-Akrad, M. AU - Witzmann, G. AU - Vesely, M. AU - Studnicka-Benke, A. AU - Gal, A. AU - Kunaver, M. AU - Zenz, P. AU - Smolen, J. S. PY - 1999 DA - 1999// TI - Cytokine production by synovial T cells in rheumatoid arthritis JO - Rheumatology (Oxford) VL - 38 UR - https://doi.org/10.1093/rheumatology/38.3.202 DO - 10.1093/rheumatology/38.3.202 ID - Steiner1999 ER - TY - JOUR AU - Matsumoto, T. AU - Tsurumoto, T. AU - Shindo, H. PY - 2006 DA - 2006// TI - Interleukin-6 levels in synovial fluids of patients with rheumatoid arthritis correlated with the infiltration of inflammatory cells in synovial membrane JO - Rheumatol Int VL - 26 UR - https://doi.org/10.1007/s00296-006-0143-2 DO - 10.1007/s00296-006-0143-2 ID - Matsumoto2006 ER - TY - JOUR AU - Sugiyama, E. AU - Kuroda, A. AU - Hori, F. AU - Hori, T. AU - Taki, H. AU - Arai, N. AU - Kobayashi, M. PY - 1995 DA - 1995// TI - Serum interleukin-6 level is a sensitive parameter of disease activity in rheumatoid arthritis JO - J Clin Rheumatol VL - 1 UR - https://doi.org/10.1097/00124743-199504000-00006 DO - 10.1097/00124743-199504000-00006 ID - Sugiyama1995 ER - TY - JOUR AU - Dayer, J. M. AU - Choy, E. PY - 2010 DA - 2010// TI - Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor JO - Rheumatology (Oxford) VL - 49 UR - https://doi.org/10.1093/rheumatology/kep329 DO - 10.1093/rheumatology/kep329 ID - Dayer2010 ER - TY - JOUR AU - Genovese, M. C. AU - Fleischmann, R. AU - Kivitz, A. J. AU - Rell-Bakalarska, M. AU - Martincova, R. AU - Fiore, S. AU - Rohane, P. AU - van Hoogstraten, H. AU - Garg, A. AU - Fan, C. PY - 2015 DA - 2015// TI - Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a phase III study JO - Arthritis Rheumatol VL - 67 UR - https://doi.org/10.1002/art.39093 DO - 10.1002/art.39093 ID - Genovese2015 ER - TY - JOUR AU - Salliot, C. AU - van der Heijde, D. PY - 2009 DA - 2009// TI - Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.093690 DO - 10.1136/ard.2008.093690 ID - Salliot2009 ER - TY - JOUR AU - Nikiphorou, E. AU - Negoescu, A. AU - Fitzpatrick, J. D. AU - Goudie, C. T. AU - Badcock, A. AU - Ostor, A. J. AU - Malaviya, A. P. PY - 2014 DA - 2014// TI - Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort JO - Clin Rheumatol VL - 33 UR - https://doi.org/10.1007/s10067-014-2546-x DO - 10.1007/s10067-014-2546-x ID - Nikiphorou2014 ER - TY - JOUR AU - Lee, S. J. AU - Chang, H. AU - Yazici, Y. AU - Greenberg, J. D. AU - Kremer, J. M. AU - Kavanaugh, A. PY - 2009 DA - 2009// TI - Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study JO - J Rheumatol VL - 36 UR - https://doi.org/10.3899/jrheum.080889 DO - 10.3899/jrheum.080889 ID - Lee2009 ER - TY - JOUR AU - Soliman, M. M. AU - Ashcroft, D. M. AU - Watson, K. D. AU - Lunt, M. AU - Symmons, D. P. AU - Hyrich, K. L. PY - 2011 DA - 2011// TI - Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.139774 DO - 10.1136/ard.2010.139774 ID - Soliman2011 ER - TY - JOUR AU - Strand, V. AU - Kosinski, M. AU - Chen, C. I. AU - Joseph, G. AU - Rendas-Baum, R. AU - Graham, N. M. AU - van Hoogstraten, H. AU - Bayliss, M. AU - Fan, C. AU - Huizinga, T. PY - 2016 DA - 2016// TI - Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial JO - Arthritis Res Ther. VL - 18 UR - https://doi.org/10.1186/s13075-016-1096-9 DO - 10.1186/s13075-016-1096-9 ID - Strand2016 ER - TY - STD TI - Fleischmann R, Castelar-Pinheiro G, Brzezicki J, Hrycaj P, Lin Y, van Adelsberg J, Graham N, van Hoogstraten H, Bauer D, Burmester G. Efficacy and safety of sarilumab in combination with Csdmards in patients with active rheumatoid arthritis who were inadequate responders or intolerant of anti-TNF therapy: results from a phase 3 study [abstract 970]. Arthritis Rheumatol. 2015;67(Suppl 10). ID - ref12 ER - TY - JOUR AU - Strand, V. AU - Reaney, M. AU - Chen, C. I. AU - Proudfoot, C. W. AU - Guillonneau, S. AU - Bauer, D. AU - Mangan, E. AU - Graham, N. M. AU - van Hoogstraten, H. AU - Lin, Y. PY - 2017 DA - 2017// TI - Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors JO - RMD Open VL - 3 UR - https://doi.org/10.1136/rmdopen-2016-000416 DO - 10.1136/rmdopen-2016-000416 ID - Strand2017 ER - TY - JOUR AU - Burmester, G. AU - Lin, Y. AU - Patel, R. AU - van Adelsberg, J. AU - Mangan, E. K. AU - Graham, N. M. H. AU - van Hoogstraten, H. AU - Bauer, D. AU - Ignacio Vargas, J. AU - Bong Lee, E. PY - 2017 DA - 2017// TI - Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-210310 DO - 10.1136/annrheumdis-2016-210310 ID - Burmester2017 ER - TY - JOUR AU - van der Elst, K. AU - Meyfroidt, S. AU - De Cock, D. AU - De Groef, A. AU - Binnard, E. AU - Moons, P. AU - Verschueren, P. AU - Westhovens, R. PY - 2016 DA - 2016// TI - Unraveling patient-preferred health and treatment outcomes in early rheumatoid arthritis: a longitudinal qualitative study JO - Arthritis Care Res (Hoboken) VL - 68 UR - https://doi.org/10.1002/acr.22824 DO - 10.1002/acr.22824 ID - van der Elst2016 ER - TY - JOUR AU - Gossec, L. AU - Dougados, M. AU - Rincheval, N. AU - Balanescu, A. AU - Boumpas, D. T. AU - Canadelo, S. AU - Carmona, L. AU - Daures, J. P. AU - de Wit, M. AU - Dijkmans, B. A. PY - 2009 DA - 2009// TI - Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.100271 DO - 10.1136/ard.2008.100271 ID - Gossec2009 ER - TY - JOUR AU - Flurey, C. A. AU - Morris, M. AU - Richards, P. AU - Hughes, R. AU - Hewlett, S. PY - 2014 DA - 2014// TI - It’s like a juggling act: rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes JO - Rheumatology (Oxford) VL - 53 UR - https://doi.org/10.1093/rheumatology/ket416 DO - 10.1093/rheumatology/ket416 ID - Flurey2014 ER - TY - JOUR AU - Cutolo, M. AU - Kitas, G. D. AU - van Riel, P. L. PY - 2014 DA - 2014// TI - Burden of disease in treated rheumatoid arthritis patients: going beyond the joint JO - Semin Arthritis Rheum VL - 43 UR - https://doi.org/10.1016/j.semarthrit.2013.08.004 DO - 10.1016/j.semarthrit.2013.08.004 ID - Cutolo2014 ER - TY - JOUR AU - Ostlund, G. AU - Bjork, M. AU - Thyberg, I. AU - Thyberg, M. AU - Valtersson, E. AU - Stenstrom, B. AU - Sverker, A. PY - 2014 DA - 2014// TI - Emotions related to participation restrictions as experienced by patients with early rheumatoid arthritis: a qualitative interview study (the Swedish TIRA project) JO - Clin Rheumatol VL - 33 UR - https://doi.org/10.1007/s10067-014-2667-2 DO - 10.1007/s10067-014-2667-2 ID - Ostlund2014 ER - TY - JOUR AU - Gossec, L. AU - Dougados, M. AU - Dixon, W. PY - 2015 DA - 2015// TI - Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis JO - RMD Open. VL - 1 UR - https://doi.org/10.1136/rmdopen-2014-000019 DO - 10.1136/rmdopen-2014-000019 ID - Gossec2015 ER - TY - BOOK PY - 2009 DA - 2009// TI - Guidance for Industry: Patient-reported outcome measures: use in medical product development to support labeling claims ID - ref21 ER - TY - JOUR AU - Felson, D. T. AU - Anderson, J. J. AU - Boers, M. AU - Bombardier, C. AU - Chernoff, M. AU - Fried, B. AU - Furst, D. AU - Goldsmith, C. AU - Kieszak, S. AU - Lightfoot, R. PY - 1993 DA - 1993// TI - The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials JO - Arthritis Rheum VL - 36 UR - https://doi.org/10.1002/art.1780360601 DO - 10.1002/art.1780360601 ID - Felson1993 ER - TY - STD TI - Ware Jr JE, Kosinski M, Bjorner JB, Turner-Bowker D, Maruish ME. User’s manual for the SF-36v2™ Health Survey. 2nd ed. Lincoln, RI: Quality Metric; 2007. ID - ref23 ER - TY - JOUR AU - Cella, D. AU - Yount, S. AU - Sorensen, M. AU - Chartash, E. AU - Sengupta, N. AU - Grober, J. PY - 2005 DA - 2005// TI - Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis JO - J Rheumatol VL - 32 ID - Cella2005 ER - TY - JOUR AU - Vliet Vlieland, T. P. AU - Zwinderman, A. H. AU - Breedveld, F. C. AU - Hazes, J. M. PY - 1997 DA - 1997// TI - Measurement of morning stiffness in rheumatoid arthritis clinical trials JO - J Clin Epidemiol VL - 50 UR - https://doi.org/10.1016/S0895-4356(97)00051-6 DO - 10.1016/S0895-4356(97)00051-6 ID - Vliet Vlieland1997 ER - TY - JOUR AU - Gossec, L. AU - Paternotte, S. AU - Aanerud, G. J. AU - Balanescu, A. AU - Boumpas, D. T. AU - Carmona, L. AU - de Wit, M. AU - Dijkmans, B. A. AU - Dougados, M. AU - Englbrecht, M. PY - 2011 DA - 2011// TI - Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.142901 DO - 10.1136/ard.2010.142901 ID - Gossec2011 ER - TY - JOUR AU - Osterhaus, J. T. AU - Purcaru, O. AU - Richard, L. PY - 2009 DA - 2009// TI - Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA) JO - Arthritis Res Ther. VL - 11 UR - https://doi.org/10.1186/ar2702 DO - 10.1186/ar2702 ID - Osterhaus2009 ER - TY - JOUR AU - Wells, G. A. AU - Tugwell, P. AU - Kraag, G. R. AU - Baker, P. R. AU - Groh, J. AU - Redelmeier, D. A. PY - 1993 DA - 1993// TI - Minimum important difference between patients with rheumatoid arthritis: the patient’s perspective JO - J Rheumatol VL - 20 ID - Wells1993 ER - TY - JOUR AU - Schiff, M. AU - Weinblatt, M. E. AU - Valente, R. AU - van der Heijde, D. AU - Citera, G. AU - Elegbe, A. AU - Maldonado, M. AU - Fleischmann, R. PY - 2014 DA - 2014// TI - Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203843 DO - 10.1136/annrheumdis-2013-203843 ID - Schiff2014 ER - TY - JOUR AU - Kremer, J. M. AU - Blanco, R. AU - Brzosko, M. AU - Burgos-Vargas, R. AU - Halland, A. M. AU - Vernon, E. AU - Ambs, P. AU - Fleischmann, R. PY - 2011 DA - 2011// TI - Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30158 DO - 10.1002/art.30158 ID - Kremer2011 ER - TY - JOUR AU - Strand, V. AU - Boers, M. AU - Idzerda, L. AU - Kirwan, J. R. AU - Kvien, T. K. AU - Tugwell, P. S. AU - Dougados, M. PY - 2011 DA - 2011// TI - It’s good to feel better but it’s better to feel good and even better to feel good as soon as possible for as long as possible: response criteria and the importance of change at OMERACT 10 JO - J Rheumatol VL - 38 UR - https://doi.org/10.3899/jrheum.110392 DO - 10.3899/jrheum.110392 ID - Strand2011 ER - TY - JOUR AU - Dworkin, R. H. AU - Turk, D. C. AU - Wyrwich, K. W. AU - Beaton, D. AU - Cleeland, C. S. AU - Farrar, J. T. AU - Haythornthwaite, J. A. AU - Jensen, M. P. AU - Kerns, R. D. AU - Ader, D. N. PY - 2008 DA - 2008// TI - Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations JO - J Pain VL - 9 UR - https://doi.org/10.1016/j.jpain.2007.09.005 DO - 10.1016/j.jpain.2007.09.005 ID - Dworkin2008 ER - TY - JOUR AU - Lubeck, D. P. PY - 2004 DA - 2004// TI - Patient-reported outcomes and their role in the assessment of rheumatoid arthritis JO - PharmacoEconomics VL - 22 UR - https://doi.org/10.2165/00019053-200422001-00004 DO - 10.2165/00019053-200422001-00004 ID - Lubeck2004 ER - TY - JOUR AU - Dougados, M. AU - Brault, Y. AU - Logeart, I. AU - van der Heijde, D. AU - Gossec, L. AU - Kvien, T. PY - 2012 DA - 2012// TI - Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID) JO - Arthritis Res Ther. VL - 14 UR - https://doi.org/10.1186/ar3859 DO - 10.1186/ar3859 ID - Dougados2012 ER - TY - JOUR AU - Krishnan, E. AU - Tugwell, P. AU - Fries, J. F. PY - 2004 DA - 2004// TI - Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI) JO - Arthritis Res Ther VL - 6 UR - https://doi.org/10.1186/ar1220 DO - 10.1186/ar1220 ID - Krishnan2004 ER - TY - JOUR AU - Webster, K. AU - Cella, D. AU - Yost, K. PY - 2003 DA - 2003// TI - The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation JO - Health Qual Life Outcomes VL - 1 UR - https://doi.org/10.1186/1477-7525-1-79 DO - 10.1186/1477-7525-1-79 ID - Webster2003 ER - TY - JOUR AU - Strand, V. AU - Rentz, A. M. AU - Cifaldi, M. A. AU - Chen, N. AU - Roy, S. AU - Revicki, D. PY - 2012 DA - 2012// TI - Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study JO - J Rheumatol VL - 39 UR - https://doi.org/10.3899/jrheum.101161 DO - 10.3899/jrheum.101161 ID - Strand2012 ER - TY - JOUR AU - Gabay, C. AU - Emery, P. AU - van Vollenhoven, R. AU - Dikranian, A. AU - Alten, R. AU - Pavelka, K. AU - Klearman, M. AU - Musselman, D. AU - Agarwal, S. AU - Green, J. PY - 2013 DA - 2013// TI - Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(13)60250-0 DO - 10.1016/S0140-6736(13)60250-0 ID - Gabay2013 ER - TY - JOUR AU - Rendas-Baum, R. AU - Bayliss, M. AU - Kosinski, M. AU - Raju, A. AU - Zwillich, S. H. AU - Wallenstein, G. V. AU - Koncz, T. PY - 2014 DA - 2014// TI - Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient’s perspective JO - Curr Med Res Opin VL - 30 UR - https://doi.org/10.1185/03007995.2014.896328 DO - 10.1185/03007995.2014.896328 ID - Rendas-Baum2014 ER - TY - JOUR AU - Kirwan, J. R. AU - de Wit, M. P. AU - Bingham, C. O. AU - Leong, A. AU - Richards, P. AU - Tugwell, P. AU - Voshaar, M. AU - Commentary, G. L. PY - 2016 DA - 2016// TI - Patients as partners: building on the experience of outcome measures in rheumatology JO - Arthritis Rheumatol. VL - 68 UR - https://doi.org/10.1002/art.39678 DO - 10.1002/art.39678 ID - Kirwan2016 ER - TY - JOUR AU - da Silva, J. A. AU - Phillips, S. AU - Buttgereit, F. PY - 2011 DA - 2011// TI - Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis JO - Scand J Rheumatol Suppl VL - 125 UR - https://doi.org/10.3109/03009742.2011.566434 DO - 10.3109/03009742.2011.566434 ID - da Silva2011 ER - TY - JOUR AU - Mittendorf, T. AU - Dietz, B. AU - Sterz, R. AU - Cifaldi, M. A. AU - Kupper, H. AU - von der Schulenburg, J. M. PY - 2008 DA - 2008// TI - Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient’s perspective JO - Rheumatology (Oxford) VL - 47 UR - https://doi.org/10.1093/rheumatology/kem317 DO - 10.1093/rheumatology/kem317 ID - Mittendorf2008 ER - TY - JOUR AU - Koike, T. AU - Harigai, M. AU - Ishiguro, N. AU - Inokuma, S. AU - Takei, S. AU - Takeuchi, T. AU - Yamanaka, H. AU - Haruna, S. AU - Ushida, N. AU - Kawana, K. PY - 2014 DA - 2014// TI - Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of 7740 patients JO - Mod Rheumatol VL - 24 UR - https://doi.org/10.3109/14397595.2013.843760 DO - 10.3109/14397595.2013.843760 ID - Koike2014 ER -